DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $354,791 | -15.8% | 1,430 | -18.5% | 0.04% | -10.6% |
Q2 2023 | $421,206 | -4.8% | 1,755 | 0.0% | 0.05% | -9.6% |
Q1 2023 | $442,333 | -5.0% | 1,755 | 0.0% | 0.05% | -10.3% |
Q4 2022 | $465,812 | +2.4% | 1,755 | -0.5% | 0.06% | -6.5% |
Q3 2022 | $455,000 | -9.5% | 1,763 | -11.2% | 0.06% | -3.1% |
Q2 2022 | $503,000 | -13.6% | 1,985 | 0.0% | 0.06% | -4.5% |
Q1 2022 | $582,000 | -10.9% | 1,985 | 0.0% | 0.07% | -5.6% |
Q4 2021 | $653,000 | +5.5% | 1,985 | -2.5% | 0.07% | -1.4% |
Q3 2021 | $619,000 | +13.4% | 2,035 | 0.0% | 0.07% | +12.5% |
Q2 2021 | $546,000 | +102.2% | 2,035 | +69.2% | 0.06% | +60.0% |
Q1 2021 | $270,000 | +1.1% | 1,203 | 0.0% | 0.04% | -2.4% |
Q4 2020 | $267,000 | +3.1% | 1,203 | 0.0% | 0.04% | -4.7% |
Q3 2020 | $259,000 | +17.7% | 1,203 | -3.5% | 0.04% | +10.3% |
Q2 2020 | $220,000 | +8.4% | 1,247 | -15.1% | 0.04% | -7.1% |
Q1 2020 | $203,000 | -6.5% | 1,469 | +3.5% | 0.04% | +7.7% |
Q4 2019 | $217,000 | +6.4% | 1,419 | 0.0% | 0.04% | 0.0% |
Q3 2019 | $204,000 | +1.0% | 1,419 | 0.0% | 0.04% | -2.5% |
Q2 2019 | $202,000 | +44.3% | 1,419 | +4.2% | 0.04% | +29.0% |
Q4 2018 | $140,000 | – | 1,362 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
Third Point | 2,900,000 | $954,129,000 | 6.66% |
Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |